i-SENS, Inc. (099190.KQ)
KRW 16060.0
(-3.37%)
KRW 16060.0
(-3.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 98.45 Billion KRW | 150.81% |
| 2022 | 39.25 Billion KRW | -26.87% |
| 2021 | 53.68 Billion KRW | 173.5% |
| 2020 | 19.62 Billion KRW | 854.16% |
| 2019 | 2.05 Billion KRW | -82.27% |
| 2018 | 11.6 Billion KRW | -20.27% |
| 2017 | 14.55 Billion KRW | 81.59% |
| 2016 | 8.01 Billion KRW | 64.49% |
| 2015 | 4.87 Billion KRW | 40.8% |
| 2014 | 3.45 Billion KRW | -75.07% |
| 2013 | 13.87 Billion KRW | 946.18% |
| 2012 | -1.63 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 91.8 Billion KRW | 0.89% |
| 2024 Q1 | 90.99 Billion KRW | -7.58% |
| 2023 Q4 | 98.45 Billion KRW | 16.65% |
| 2023 Q1 | 38.83 Billion KRW | -1.07% |
| 2023 Q2 | 58.39 Billion KRW | 50.37% |
| 2023 FY | 98.45 Billion KRW | 150.81% |
| 2023 Q3 | 84.4 Billion KRW | 44.53% |
| 2022 FY | 39.25 Billion KRW | -26.87% |
| 2022 Q1 | 47.46 Billion KRW | -11.58% |
| 2022 Q3 | 39.05 Billion KRW | -8.6% |
| 2022 Q4 | 39.25 Billion KRW | 0.51% |
| 2022 Q2 | 42.73 Billion KRW | -9.96% |
| 2021 FY | 53.68 Billion KRW | 173.5% |
| 2021 Q1 | 2.28 Billion KRW | -87.66% |
| 2021 Q2 | -1.76 Billion KRW | -177.17% |
| 2021 Q4 | 53.68 Billion KRW | 365.24% |
| 2021 Q3 | 11.53 Billion KRW | 754.96% |
| 2020 Q1 | -3.67 Billion KRW | -419.58% |
| 2020 Q3 | 11.4 Billion KRW | 286.09% |
| 2020 FY | 19.62 Billion KRW | 854.16% |
| 2020 Q4 | 18.49 Billion KRW | 62.16% |
| 2020 Q2 | -6.12 Billion KRW | -66.78% |
| 2019 Q1 | 9.56 Billion KRW | -17.51% |
| 2019 FY | 2.05 Billion KRW | -82.27% |
| 2019 Q3 | -5.46 Billion KRW | -220.27% |
| 2019 Q2 | 4.54 Billion KRW | -52.49% |
| 2019 Q4 | 1.14 Billion KRW | 121.03% |
| 2018 Q4 | 11.6 Billion KRW | 7.77% |
| 2018 Q1 | 12.85 Billion KRW | -11.63% |
| 2018 Q2 | 12.77 Billion KRW | -0.67% |
| 2018 FY | 11.6 Billion KRW | -20.27% |
| 2018 Q3 | 10.76 Billion KRW | -15.72% |
| 2017 Q4 | 14.55 Billion KRW | -46.85% |
| 2017 Q3 | 27.37 Billion KRW | 0.78% |
| 2017 Q1 | 11.11 Billion KRW | 14.42% |
| 2017 FY | 14.55 Billion KRW | 81.59% |
| 2017 Q2 | 27.16 Billion KRW | 144.43% |
| 2016 Q3 | 2.63 Billion KRW | -66.67% |
| 2016 FY | 8.01 Billion KRW | 64.49% |
| 2016 Q4 | 9.71 Billion KRW | 268.87% |
| 2016 Q2 | 7.9 Billion KRW | 30.83% |
| 2016 Q1 | 6.03 Billion KRW | 23.98% |
| 2015 Q2 | 1.46 Billion KRW | 560.64% |
| 2015 FY | 4.87 Billion KRW | 40.8% |
| 2015 Q1 | -317.37 Million KRW | -109.17% |
| 2015 Q4 | 4.87 Billion KRW | -23.89% |
| 2015 Q3 | 6.4 Billion KRW | 337.79% |
| 2014 Q3 | 1.97 Billion KRW | -75.97% |
| 2014 FY | 3.45 Billion KRW | -75.07% |
| 2014 Q2 | 8.2 Billion KRW | -3.27% |
| 2014 Q4 | 3.45 Billion KRW | 75.38% |
| 2014 Q1 | 8.48 Billion KRW | -38.84% |
| 2013 Q1 | -714.46 Million KRW | 56.43% |
| 2013 Q3 | -1.34 Billion KRW | -175.9% |
| 2013 Q4 | 13.87 Billion KRW | 1129.81% |
| 2013 Q2 | 1.77 Billion KRW | 348.47% |
| 2013 FY | 13.87 Billion KRW | 946.18% |
| 2012 FY | -1.63 Billion KRW | 0.0% |
| 2012 Q4 | -1.63 Billion KRW | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | -108.91 Billion KRW | 190.395% |
| InBody Co.,Ltd | -16.2 Billion KRW | 707.543% |
| Curexo Inc. | -15.03 Billion KRW | 754.955% |
| Seegene, Inc. | -48.57 Billion KRW | 302.681% |
| Ray Co., Ltd. | 67.09 Billion KRW | -46.742% |
| Gencurix Inc. | 15.02 Billion KRW | -555.275% |
| Sugentech Inc. | -6.95 Billion KRW | 1516.34% |
| L&C Bio Co., Ltd | 67.18 Billion KRW | -46.546% |